[1]
|
Lazar, M.A. (1993) Thyroid hormone receptors: Multiple forms, multiple possibilities. Endocrine Reviews, 14, 184-193.
|
[2]
|
Hsia, S.C. and Shi, Y.B. (2002) Chromatin disruption and histone acetylation in regulation of the human immunodeficiency virus type 1 long terminal repeat by thyroid hormone receptor. Molecular and Cellular Biology, 22, 4043-4052. doi:10.1128/MCB.22.12.4043-4052.2002
|
[3]
|
Hsia, S.C., Bedadala, G.R. and Balish, M.D. (2011) Effects of thyroid hormone on HSV-1 gene regulation: Implications in the control of viral latency and reactivation. Cell Bioscience, 1, 24. doi:10.1186/2045-3701-1-24
|
[4]
|
Bedadala, G.R., Pinnoji, R.C., Palem, J.R. and Hsia, S.C. (2010) Thyroid hormone controls the gene expression of HSV-1 LAT and ICP0 in neuronal cells. Cell Research, 20, 587-598. doi:10.1038/cr.2010.50
|
[5]
|
Hsia, S.C., Pinnoji, R.C., Bedadala, G.R., Hill, J.M. and Palem, J.R. (2010) Regulation of herpes simplex virus type 1 thymidine kinase gene expression by thyroid hormone receptor in cultured neuronal cells. Journal of NeuroVirology, 16, 13-24.
doi:10.3109/13550280903552412
|
[6]
|
Taylor, T.J., Brockman, M.A., McNamee, E.E. and Knipe, D.M. (2002) Herpes simplex virus. Front Bioscience, 7, d752-764. doi:10.2741/taylor
|
[7]
|
Xu, F., Sternberg, M.R., Kottiri, B.J., McQuillan, G.M., Lee, F.K., Nahmias, A.J., Berman, S.M. and Markowitz, L.E. (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA, 296, 964-973. doi:10.1001/jama.296.8.964
|
[8]
|
Hill, J.M., Wen, R. and Halford, W.P. (1998) Pathogenesis and molecular biology of HSV latency and ocular reactivation in the rabbit. Methods in Molecular Medicine, 10, 291-315.
|
[9]
|
Martinez, P.A., Diaz, R., Gonzalez, D., Oropesa, L., Gonzalez, R., Perez, L., Viera, J. and Kouri, V. (2007) The effect of highly active antiretroviral therapy on outcome of central nervous system herpesviruses infection in Cuban human immunodeficiency virus-infected individuals. Journal of NeuroVirology, 13, 446-451.
doi:10.1080/13550280701510088
|
[10]
|
Shah, A., Farooq, A.V., Tiwari, V., Kim, M.J. and Shukla, D. (2010) HSV-1 infection of human corneal epithelial cells: Receptor-mediated entry and trends of re-infection. Molecular Vision, 16, 2476-2486.
|
[11]
|
Jonsson, M.K. and Wahren, B. (2004) Sexually transmitted herpes simplex viruses. Scandinavian Journal of Infectious Diseases, 36, 93-101.
doi:10.1080/00365540310018905
|
[12]
|
Goel, N., Mao, H., Rong, Q., Docherty, J.J., Zimmerman, D. and Rosenthal, K.S. (2002) The ability of an HSV strain to initiate zosteriform spread correlates with its neuroinvasive disease potential. Archives of Virology, 147, 763-773. doi:10.1007/s007050200024
|
[13]
|
Walter, I.B. and Droz, B. (1995) Nuclear and cytoplasmic triiodothyronine-binding sites in primary sensory neurons and Schwann cells: Radioautographic study during development. Journal of Neuroendocrinology, 7, 127-136.
doi:10.1111/j.1365-2826.1995.tb00675.x
|
[14]
|
Glauser, L. and Barakat Walter, I. (1997) Differential distribution of thyroid hormone receptor isoform in rat dorsal root ganglia and sciatic nerve in vivo and in vitro. Journal of Neuroendocrinology, 9, 217-227.
doi:10.1046/j.1365-2826.1997.d01-1088.x
|
[15]
|
Walter, I.B. (1996) Triiodothyronine exerts a trophic action on rat sensory neuron survival and neurite outgrowth through different pathways. European Journal of Neuroscience, 8, 455-466.
doi:10.1111/j.1460-9568.1996.tb01229.x
|
[16]
|
Barakat-Walter, I. and Riederer, B.M. (1996) Triiodothyronine and nerve growth factor are required to induce cytoplasmic dynein expression in rat dorsal root ganglion cultures. Developmental Brain Research, 96, 109-119.
|
[17]
|
De Vito, P., Balducci, V., Leone, S., Percario, Z., Mangino, G., Davis, P.J., Davis, F.B., Affabris, E., Luly, P., Pedersen, J.Z. and Incerpi, S. (2012) Nongenomic effects of thyroid hormones on the immune system cells: New targets, old players. Steroids, 77, 988-995.
doi:10.1016/j.steroids.2012.02.018
|
[18]
|
De Vito, P., Incerpi, S., Pedersen, J.Z., Luly, P., Davis, F.B. and Davis, P.J. (2011) Thyroid hormones as modulators of immune activities at the cellular level. Thyroid, 21, 879-890. doi:10.1089/thy.2010.0429
|
[19]
|
Paavonen, T. (1982) Enhancement of human B lymphocyte differentiation in vitro by thyroid hormone. Scandinavian Journal of Immunology, 15, 211-215.
doi:10.1111/j.1365-3083.1982.tb00640.x
|
[20]
|
Provinciali, M., Muzzioli, M., Di Stefano, G. and Fabris, N. (1991) Recovery of spleen cell natural killer activity by thyroid hormone treatment in old mice. Natural Immunity and Cell Growth Regulation, 10, 226-236.
|
[21]
|
Provinciali, M., Muzzioli, M. and Fabris, N. (1987) Thyroxine-dependent modulation of natural killer activity. Journal of Experimental Pathology, 3, 617-622.
|
[22]
|
Provinciali, M. and Fabris, N. (1990) Modulation of lymphoid cell sensitivity to interferon by thyroid hormones. Journal of Endocrinological Investigation, 13, 187-191.
|
[23]
|
Lin, H.Y., Yen, P.M., Davis, F.B. and Davis, P.J. (1997) Protein synthesis-dependent potentiation by thyroxine of antiviral activity of interferon-gamma. American Journal of Physiology, 273, C1225-1232.
|
[24]
|
Lin, H.Y., Thacore, H.R., Davis, P.J. and Davis, F.B. (1994) Thyroid hormone potentiates the antiviral action of interferon-gamma in cultured human cells. The Journal of Clinical Endocrinology & Metabolism, 79, 62-65.
doi:10.1210/jc.79.1.62
|
[25]
|
Marquart, M., Bhattacharjee, P., Zheng, X., Kaufman, H., Thompson, H., Varnell, E. and Hill, J. (2003) Ocular reactivation phenotype of HSV-1 strain F(MP)E, a corticosteroid-sensitive strain. Current Eye Research, 26, 205-209. doi:10.1076/ceyr.26.3.205.14890
|
[26]
|
Higaki, S., Gebhardt, B.M., Lukiw, W.J., Thompson, H.W. and Hill, J.M. (2002) Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion. Investigative Ophthalmology & Visual Science, 43, 1862-1869.
|
[27]
|
Doherty, M.J., Baxter, A.B. and Longstreth Jr., W.T. (2001) Herpes simplex virus encephalitis complicating myxedema coma treated with corticosteroids. Neurology, 56, 1114-1115. doi:10.1212/WNL.56.8.1114
|